MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-06-30, SAGE has $422,922K in assets. $54,185K in debts. $67,487K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
916.37%
Quick Ratio
916.37%
Cash Ratio
151.17%
Debt to Asset Ratio
12.81%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liability, net o...
    • Others

Balance Sheets
2025-06-30
Prepaid expenses and other current assets
19,138
Other receivable
8,105
Marketable securities
298,085
Cash and cash equivalents
67,487
Collaboration receivable - related party
16,270
Total current assets
409,085
Restricted cash
1,450
Property and equipment, net
674
Other long-term assets
1,756
Right-of-use operating asset
9,957
Total assets
422,922
Accrued expenses
42,072
Operating lease liability, current portion
1,878
Accounts payable
692
Total current liabilities
44,642
Operating lease liability, net of current portion
9,543
Total liabilities
54,185
Treasury stock, at cost, 3,033 shares at june 30, 2025 and december 31, 2024
400
Accumulated deficit
-3,082,191
Common stock, 0.0001 par value per share 120,000,000 shares authorized at june 30, 2025 and december 31, 2024 62,631,252 and 61,359,242 shares issued at june 30, 2025 and december 31, 2024, respectively 62,628,219 and 61,356,209 shares outstanding at june 30, 2025 and december 31, 2024, respectively
6
Additional paid-in capital
3,451,307
Accumulated other comprehensive income
15
Total stockholders equity
368,737
Total liabilities and stockholders equity
422,922
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$298,085K Cash and cashequivalents$67,487K Prepaid expenses andother current assets$19,138K Collaboration receivable -related party$16,270K Other receivable$8,105K Total current assets$409,085K Right-of-use operating asset$9,957K Other long-termassets$1,756K Restricted cash$1,450K Property and equipment,net$674K Total assets$422,922K Total liabilities andstockholders equity$422,922K Total stockholdersequity$368,737K Total liabilities$54,185K Accumulated deficit-$3,082,191K Treasury stock, at cost,3,033 shares at june...$400K Additional paid-in capital$3,451,307K Total currentliabilities$44,642K Operating leaseliability, net of current...$9,543K Accumulated othercomprehensive income$15K Common stock, 0.0001par value per share...$6K Accrued expenses$42,072K Operating leaseliability, current portion$1,878K Accounts payable$692K

Sage Therapeutics, Inc. (SAGE)

Sage Therapeutics, Inc. (SAGE)